Tagged Articles

Avandia lawsuits 1 articles

Dark cloud hangs over Avandia despite FDA vote to keep it on market

After two days of deliberation, a Food and Drug Administration (FDA) advisory panel voted Wednesday to keep the diabetes drug Avandia on the market despite studies that suggest the medication puts people at greater risk of heart attacks and strokes. The decision was hardly decisive. Among five possible recommendations, the option to withdraw Avandia from the market received the most votes, however a majority voted to keep it on the market in some form. Thus the drug will still be available. But don’t expect physicians to write as many prescriptions for the Type 2 diabetes drug as they have in ... Read More